Carlo Felizardo is an associate in the Washington, DC office of Gibson, Dunn & Crutcher. He is a member of the firm’s FDA and Health Care practice.
Carlo has extensive experience advising companies involved in the development, manufacturing, marketing, and distribution of U.S. Food and Drug Administration (FDA)-regulated products. He assists clients in interpreting, implementing, and ensuring compliance with FDA requirements across a wide array of product classes, including drugs, medical devices, and biological products.
Carlo also works with various entities involved in life sciences transactions to understand and mitigate potential regulatory risks. He has extensive experience in conducting FDA regulatory due diligence and drafting key disclosure and transactional language.
Carlo earned his law degree, cum laude, in 2016 from Northwestern University. He received his bachelor’s degree with high honors in political science and sociology and anthropology from Swarthmore College in 2011, and his master’s degree in sociology from Northwestern University in 2013.
Carlo is admitted to practice in Illinois and the District of Columbia.
Prior to joining Gibson Dunn, Carlo was an associate in the FDA practice at another global firm.
Capabilities
Credentials
Education:
- Northwestern University - 2016 Juris Doctor
- Northwestern University - 2013 Master of Arts
- Swarthmore College - 2011 Bachelor of Arts
Admissions:
- District of Columbia Bar
- Illinois Bar
News & Insights
Client Alert
FDA’s User Fee Programs at a Crossroads: User Fee Deadlines and Funding at Risk
Client Alert
A Storm Brewing: Kennedy Directs FDA to Revamp Pathway for Establishing Safety of Food Ingredients
Firm News
Gibson Dunn Advises J.P. Morgan on Participation as Lead Investor in Series C Financing Round of Olipop